Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
伊立替康联合S-1治疗吉西他滨难治性胰腺癌患者的随机II期临床试验
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2016.436
Ioka, T; Komatsu, Y; Mizuno, N; Tsuji, A; Ohkawa, S; Tanaka, M; Iguchi, H; Ishiguro, A; Kitano, M; Satoh, T; Yamaguchi, T; Takeda, K; Kida, M; Eguchi, K; Ito, T; Munakata, M; Itoi, T; Furuse, J; Hamada, C; Sakata, Y